Published: 14 September 2017
Author(s): Ivan Gentile, Antonio Riccardo Buonomo, Riccardo Scotto, Emanuela Zappulo, Guglielmo Borgia
Section: Letter to the Editor

Cirrhosis is the end stage of various diseases of the liver. The leading causes of liver diseases are hepatitis B and C viral infections (HBV and HCV), alcohol consumption and cryptogenetic disease [1]. Thanks to the advent of nucleot(s)ide HBV analogs and direct anti HCV agents, the long-term survival of patients affected by liver cirrhosis has improved significantly in recent years [2–4]. Nevertheless, even in case of viral suppression or viral clearance, patients with liver cirrhosis remain at risk for decompensation, hepatocellular carcinoma (HCC) and death.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.